| 英文别名 |
2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid;Ixazomib citrate;2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid;MLN 9708;MLN9708;Ixazomib citrate (Ester);46CWK97Z3K;Ixazomib citrate [USAN];1,3,2-Dioxaborolane-4,4-diacetic acid, 2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo-;1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-;Ninlaro (TN);Ixazomib citr;(R)-2,2'-(2-(1-(2-(2,5-Dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid;s4432;2-[4-(carboxymethyl)-2-[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid;AKOS030632768;Ixazomib Citrate (MLN-9708)?;IXAZOMIB CITRATE [JAN];DA-54493;NCGC00522453-01;SCHEMBL4427479;HY-10452;BCP16600;2,2'-(2-((1R)-1-((N-(2,5-DICHLOROBENZOYL)GLYCYL)AMINO)-3-METHYLBUTYL)-5-OXO-1,3,2-DIOXABOROLANE-4,4-DIYL)DIACETIC ACID;NSC767907;NCGC00522453-02;AS-75031;D10131;1239908-20-3;NINLARO;2,2'-{2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid;GLXC-10711;2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoy)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid;MBOMYENWWXQSNW-AWEZNQCLSA-N;IXAZOMIB CITRATE [WHO-DD];CHEMBL3545432;DTXSID60924652;UNII-46CWK97Z3K;BRD-K15203492-001-01-1;CHEBI:90939;MLN9708; MLN-9708; MLN 9708;Ixazomib-prodrug;EX-A3660;CS-1720;C71946;Q27162929;IXAZOMIB CITRATE [MI];NSC-767907;Ixazomib citrate (JAN/USAN);IXAZOMIB CITRATE [ORANGE BOOK];2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid;AC-35344 |